177 related articles for article (PubMed ID: 34550356)
1. A synthetic lethal screen identifies HDAC4 as a potential target in MELK overexpressing cancers.
Zhou L; Zheng S; Rosas Bringas FR; Bakker B; Simon JE; Bakker PL; Kazemier HG; Schubert M; Roorda M; van Vugt MATM; Chang M; Foijer F
G3 (Bethesda); 2021 Dec; 11(12):. PubMed ID: 34550356
[TBL] [Abstract][Full Text] [Related]
2. Maternal embryonic leucine zipper kinase (MELK): a novel regulator in cell cycle control, embryonic development, and cancer.
Jiang P; Zhang D
Int J Mol Sci; 2013 Oct; 14(11):21551-60. PubMed ID: 24185907
[TBL] [Abstract][Full Text] [Related]
3. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.
Lin ML; Park JH; Nishidate T; Nakamura Y; Katagiri T
Breast Cancer Res; 2007; 9(1):R17. PubMed ID: 17280616
[TBL] [Abstract][Full Text] [Related]
4. A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells.
Reid RJ; Du X; Sunjevaric I; Rayannavar V; Dittmar J; Bryant E; Maurer M; Rothstein R
Genetics; 2016 Oct; 204(2):807-819. PubMed ID: 27558135
[TBL] [Abstract][Full Text] [Related]
5. Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.
Chlenski A; Park C; Dobratic M; Salwen HR; Budke B; Park JH; Miller R; Applebaum MA; Wilkinson E; Nakamura Y; Connell PP; Cohn SL
Mol Cancer Ther; 2019 Mar; 18(3):507-516. PubMed ID: 30674566
[TBL] [Abstract][Full Text] [Related]
6. Maternal embryonic leucine zipper kinase in tumor cells and tumor microenvironment: An emerging player and promising therapeutic opportunity.
Tang BF; Yan RC; Wang SW; Zeng ZC; Du SS
Cancer Lett; 2023 Apr; 560():216126. PubMed ID: 36933780
[TBL] [Abstract][Full Text] [Related]
7. Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer.
Duffy S; Fam HK; Wang YK; Styles EB; Kim JH; Ang JS; Singh T; Larionov V; Shah SP; Andrews B; Boerkoel CF; Hieter P
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):9967-76. PubMed ID: 27551064
[TBL] [Abstract][Full Text] [Related]
8. Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer.
Chung S; Suzuki H; Miyamoto T; Takamatsu N; Tatsuguchi A; Ueda K; Kijima K; Nakamura Y; Matsuo Y
Oncotarget; 2012 Dec; 3(12):1629-40. PubMed ID: 23283305
[TBL] [Abstract][Full Text] [Related]
9. Suppressor analysis of a histone defect identifies a new function for the hda1 complex in chromosome segregation.
Kanta H; Laprade L; Almutairi A; Pinto I
Genetics; 2006 May; 173(1):435-50. PubMed ID: 16415367
[TBL] [Abstract][Full Text] [Related]
10. Promoter-dependent roles for the Srb10 cyclin-dependent kinase and the Hda1 deacetylase in Tup1-mediated repression in Saccharomyces cerevisiae.
Green SR; Johnson AD
Mol Biol Cell; 2004 Sep; 15(9):4191-202. PubMed ID: 15240822
[TBL] [Abstract][Full Text] [Related]
11. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
Inoue H; Kato T; Olugbile S; Tamura K; Chung S; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y; Park JH
Oncotarget; 2016 Mar; 7(12):13621-33. PubMed ID: 26871945
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the Role of the Maternal Embryonic Leucine Zipper Kinase in Adrenocortical Carcinoma.
Kiseljak-Vassiliades K; Zhang Y; Kar A; Razzaghi R; Xu M; Gowan K; Raeburn CD; Albuja-Cruz M; Jones KL; Somerset H; Fishbein L; Leong S; Wierman ME
Endocrinology; 2018 Jul; 159(7):2532-2544. PubMed ID: 29790920
[TBL] [Abstract][Full Text] [Related]
13. MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells.
Beke L; Kig C; Linders JT; Boens S; Boeckx A; van Heerde E; Parade M; De Bondt A; Van den Wyngaert I; Bashir T; Ogata S; Meerpoel L; Van Eynde A; Johnson CN; Beullens M; Brehmer D; Bollen M
Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26431963
[TBL] [Abstract][Full Text] [Related]
14. A novel carbon-11 radiolabeled maternal embryonic leucine zipper kinase inhibitor for PET imaging of triple-negative breast cancer.
Tang R; Gai Y; Li K; Hu F; Gong C; Wang S; Feng F; Altine B; Hu J; Lan X
Bioorg Chem; 2021 Feb; 107():104609. PubMed ID: 33454507
[TBL] [Abstract][Full Text] [Related]
15. Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma.
Bolomsky A; Heusschen R; Schlangen K; Stangelberger K; Muller J; Schreiner W; Zojer N; Caers J; Ludwig H
Haematologica; 2018 Feb; 103(2):325-335. PubMed ID: 29122991
[TBL] [Abstract][Full Text] [Related]
16. High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo.
Ikeda Y; Sato S; Yabuno A; Shintani D; Ogasawara A; Miwa M; Zewde M; Miyamoto T; Fujiwara K; Nakamura Y; Hasegawa K
J Gynecol Oncol; 2020 Nov; 31(6):e93. PubMed ID: 33078598
[TBL] [Abstract][Full Text] [Related]
17. Enigmatic MELK: The controversy surrounding its complex role in cancer.
McDonald IM; Graves LM
J Biol Chem; 2020 Jun; 295(24):8195-8203. PubMed ID: 32350113
[TBL] [Abstract][Full Text] [Related]
18. Arrestin-3 interaction with maternal embryonic leucine-zipper kinase.
Perry NA; Fialkowski KP; Kaoud TS; Kaya AI; Chen AL; Taliaferro JM; Gurevich VV; Dalby KN; Iverson TM
Cell Signal; 2019 Nov; 63():109366. PubMed ID: 31352007
[TBL] [Abstract][Full Text] [Related]
19. MELK is not necessary for the proliferation of basal-like breast cancer cells.
Huang HT; Seo HS; Zhang T; Wang Y; Jiang B; Li Q; Buckley DL; Nabet B; Roberts JM; Paulk J; Dastjerdi S; Winter GE; McLauchlan H; Moran J; Bradner JE; Eck MJ; Dhe-Paganon S; Zhao JJ; Gray NS
Elife; 2017 Sep; 6():. PubMed ID: 28926338
[TBL] [Abstract][Full Text] [Related]
20. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer.
Wang J; Wang Y; Shen F; Xu Y; Zhang Y; Zou X; Zhou J; Chen Y
Cancer Med; 2018 Nov; 7(11):5665-5678. PubMed ID: 30334367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
